Peter Lind
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
-
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 10
-
- Radiopharmaceutical Chemistry and Applications 4
- Medical Imaging Techniques and Applications 3
- Radiomics and Machine Learning in Medical Imaging 2
- Co-authors
- E. Kresnik (9 shared papers)Peter Mikosch (8 shared papers)Susanne Kohlfürst (3 shared papers)Isabel Igerc (4 shared papers)H. J. Gallowitsch (3 shared papers)Iris Gomez (4 shared papers)G. Kumnig (2 shared papers)Johann Gasser (2 shared papers)
In The Last Decade
Peter Lind
20 papers receiving 742 citations
Peers
Comparison fields: 5 of 77
- Endocrinology, Diabetes and Metabolism 268
- Radiology, Nuclear Medicine and Imaging 279
- Virology 48
- Infectious Diseases 66
- Epidemiology 112
Countries citing papers authored by Peter Lind
This map shows the geographic impact of Peter Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lind more than expected).
Fields of papers citing papers by Peter Lind
This network shows the impact of papers produced by Peter Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lind. The network helps show where Peter Lind may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 137 | |
| 2 | 1996 | 104 | |
| 3 | 2015 | 101 | |
| 4 | 2006 | 81 | |
| 5 | 2006 | 66 | |
| 6 | 2010 | 64 | |
| 7 | Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. | 1997 | 51 |
| 8 | Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. | 1998 | 35 |
| 9 | 1999 | 34 | |
| 10 | 2000 | 26 | |
| 11 | 1997 | 24 | |
| 12 | 1990 | 16 | |
| 13 | 2003 | 10 | |
| 14 | 2008 | 7 | |
| 15 | 2003 | 5 | |
| 16 | 1996 | 3 | |
| 17 | 2005 | 1 | |
| 18 | Baggrundsundersøgelser ifm. udarbejdelse af Nationale Annekser til EN1990 og EN1991 | 2009 | 1 |
| 19 | 2007 | 1 | |
| 20 | 1997 | 1 |
About Peter Lind
Peter Lind is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases, having authored 20 papers that have together received 768 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Medical Imaging Techniques and Applications (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Medical Imaging and Pathology Studies (2 papers), Click Chemistry and Applications (1 paper) and Medical and Biological Sciences (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (268 citations), Radiology, Nuclear Medicine and Imaging (279 citations), Virology (48 citations), Infectious Diseases (66 citations) and Epidemiology (112 citations). Peter Lind has collaborated with scholars based in Austria, Sweden and Denmark. Frequent co-authors include E. Kresnik, Peter Mikosch, Susanne Kohlfürst, Isabel Igerc, H. J. Gallowitsch, Iris Gomez, G. Kumnig, Johann Gasser, Jacobo Cal-González and Ivo Rausch. Their work appears in journals such as Investigative Radiology, European Journal of Nuclear Medicine and Molecular Imaging, Seminars in Nuclear Medicine, Neuroendocrinology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.